CIBA-GEIGY ACCUTRIM USE OF ALZA's OROS TIMED-RELEASE SYSTEM MAKES PRODUCT A NEW DRUG BECAUSE OF "NEW AND UNIQUE" MECHANISM, FDA TELLS FIRM